Novartis AG ( NVS) - Key Metrics
NVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $7.25 | $1.61 | $1.12 | $0.80 |
| 2025Q3 | $7.37 | $2.02 | $3.37 | $2.95 |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $7.62 | $2.07 | $3.42 | $3.13 |
NVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 3.36% | 21.51 |
| 2025Q3 | 5.55% | 15.58 |
| 2025Q3 | ? | ? |
| 2025Q2 | 61.49% | 14.61 |
NVS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.98% | ? |
| 2025Q4 | 0.62% | 0.04% |
| 2025Q3 | 2.34% | 0.09% |
| 2025Q3 | 2.40% | ? |
| 2025Q2 | 2.59% | 1.05% |
NVS
List: Challengers
Price: $148.58
Dividend Yield: 3.28%
Forward Dividend Yield: 3.22%
Payout Ratio: 77.24%
Dividend Per Share: 4.77 USD
Earnings Per Share: 6.98 USD
P/E Ratio: 21.00
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Volume: 1.7 million
Ebitda: 2.5 billionMarket Capitalization: 277.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 30
DGR3: 6.30%
DGR5: 5.29%
DGR10: 4.91%
DGR20: 8.93%